How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

David Foster Wallace, the late author of ‘Infinite Jest’, a book that’s many contradictory things: self-aware and indulgent, thoughtful and ostentatious, sentimental and nasty, deeply personal and ...

Forget its reputation as a performative read for a certain breed of intense young man, thirty years after its publication, David Foster Wallace’s epic novel still delivers, says the Crying in H Mart ...

Robin has worked as a credit cards, editor and spokesperson for over a decade. Prior to Forbes Advisor, she also covered credit cards and related content for other national web publications including ...